GT BIOPHARMA
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immunology therapeutic products based on our proprietary Trispecific Killer Engagers (TriKE™) target-directed Natural Killer (NK) cell engager platform. The TriKE™ NK protein biologic platform is designed to harness and amplify the body’s native immune system for hope for patients with cancer and infectious diseases.
GT BIOPHARMA
Industry:
Biotechnology Health Care Medical
Founded:
1965-01-01
Address:
Westlake Village, California, United States
Country:
United States
Website Url:
http://www.gtbiopharma.com
Total Employee:
1+
Status:
Active
Contact:
310-860-5184
Total Funding:
88.33 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Apache Microsoft Exchange Online Amazon
Similar Organizations
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2005-09-21 | BioCheck | BioCheck acquired by GT Biopharma | 6 M USD |
| 1998-01-06 | Innovative Medical Systems | Innovative Medical Systems acquired by GT Biopharma | N/A |
Investors List
Armando Soto
Armando Soto investment in Post-IPO Equity - GT Biopharma
Key Employee Changes
| Date | New article |
|---|---|
| 2022-02-18 | GT Biopharma Appoints Manu Ohri as Chief Financial Officer |
Official Site Inspections
http://www.gtbiopharma.com
- Host name: ec2-54-208-101-55.compute-1.amazonaws.com
- IP address: 54.208.101.55
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "GT Biopharma"
Management Team :: GT Biopharma, Inc. (GTBP)
Michael Breen. Executive Chairman, Board of Directors, Interim Chief Executive Officer. Michael Breen is an English qualified solicitor/attorney and was formerly the Managing Director of the …See details»
Profile :: GT Biopharma, Inc. (GTBP)
GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical stage immuno-oncology company focused on developing innovative therapies based on the Company's proprietary NK cell engager (TriKE …See details»
GT Biopharma, Inc. (GTBP) Company Profile & Facts - Yahoo Finance
See the company profile for GT Biopharma, Inc. (GTBP) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
GT Biopharma - Crunchbase Company Profile & Funding
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of immunology therapeutic products …See details»
GT Biopharma, Inc. | LinkedIn
GT Biopharma, Inc. | 899 followers on LinkedIn. Focused on the next generation of immunotherapies by leveraging our proprietary TriKE platform technology. (NASDAQ:GTBP) | Using our proprietary ...See details»
GT Biopharma (GTBP) Company Profile & Description
6 days ago GT Biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein …See details»
GT Biopharma Announces Executive Leadership Transition to …
For more information, please visit gtbiopharma.com. Forward-Looking Statements This press release contains certain forward-looking statements that involve risks, uncertainties and …See details»
GT Biopharma Appoints Two New Independent Directors
Michael Breen is an English qualified solicitor/attorney and was formerly the Managing Director of the Sports and Entertainment Division of Bank Insinger de Beaufort N. V., which is a wealth …See details»
GT Biopharma, Inc. (GTBP) Stock Price, News, Quote & History
Www.gtbiopharma.com . 1. Full Time Employees. December 31. Fiscal Year Ends. Healthcare. Sector. Biotechnology. Industry. More about GT Biopharma, Inc. Recent News: GTBP View …See details»
Board of Directors :: GT Biopharma, Inc. (GTBP)
Michael Breen. Executive Chairman, Board of Directors, Interim Chief Executive Officer . Michael Breen is an English qualified solicitor/attorney and was formerly the Managing Director of the …See details»
GT Biopharma - Overview, News & Similar companies - ZoomInfo
Jun 9, 2024 GT Biopharma contact info: Phone number: (415) 919-4040 Website: www.gtbiopharma.com What does GT Biopharma do? GT Biopharma, Inc. is a clinical stage …See details»
Investor Relations :: GT Biopharma, Inc. (GTBP)
Sign up for email alerts. Be the first to receive breaking news. Sign up todaySee details»
GT Biopharma Announces Executive Leadership Transition to …
Nov 8, 2021 [email protected] 414-351-9758 . LifeSci Advisors Corey Davis, Ph.D. [email protected] 212-915-2577 . View original content ...See details»
GT Biopharma 2025 Company Profile: Stock Performance
GT Biopharma General Information Description. GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel …See details»
GT Biopharma, Inc. (GT Biopharma, Inc.) - 药物管线_专利_临床试 …
了解GT Biopharma, Inc. (GT Biopharma, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 44篇新闻和3篇文献，疾病领域:肿瘤，血液及淋巴系统疾病，免疫系统疾病，感 …See details»
Overview :: GT Biopharma, Inc. (GTBP)
Overview. GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical stage immuno-oncology company focused on innovative therapies based on the Company's proprietary NK cell engager (TriKE …See details»
GT BioPharma to Host a Management Update Conference Call
BEVERLY HILLS, Calif., Nov. 24, 2021 /PRNewswire/ -- GT Biopharma, Inc. (the 'Company') (NASDAQ: GTBP), a clinical stage immuno-oncology company f...See details»
GT Biopharma, Inc. (GTBP) - Yahoo Finance
Find the latest GT Biopharma, Inc. (GTBP) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Establishing Canada’s first large-scale bioinnovation centre
Mar 20, 2025 Today, the Honourable Darren Fisher, Member of Parliament for Dartmouth – Cole Harbour, announced a $5 million, non-repayable contribution to Neptune BioInnovation Inc. to …See details»
Our Technologies :: GT Biopharma, Inc. (GTBP)
Our Technologies. Tri-specific NK cell Engagers (TriKEs) and Dual Targeting NK cell Engagers. The generation of Chimeric Antigen Receptor, or CAR, expressing T cells from monoclonal …See details»